Dr. Prasad Vrk Chalasani, MD

Dr. Chalasani practices at Florida Heart Center, PA in Fort Pierce, Florida.

Dr. Chalasani's NPI, 1760477269, was assigned on September 12, 2005. Dr. Chalasani graduated from Andhra Medical College NTR in 1987. Dr. Chalasani holds Florida license ME0072976.

Dr. Chalasani's primary practice is Florida Heart Center, PA, at 1900 Nebraska Ave, Fort Pierce, FL 34950 in Saint Lucie County. The practice phone is (772) 465-4757.

Dr. Chalasani's primary practice is Florida Heart Center, PA in Fort Pierce, Florida. Dr. Chalasani is also affiliated with HCA Florida Lawnwood Hospital. The medical group on file is Florida Heart Center. Dmand AI also links Dr. Chalasani to 3 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chalasani practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chalasani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Chalasani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Chalasani's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Chalasani treats.

CMS data shows 20,263 Medicare services from Dr. Chalasani across 46 procedure codes in 2024, for 2,532 Medicare patients. Medicare paid $1,272,695 for them.

CMS counts 2,532 Medicare patients who saw Dr. Chalasani in 2024. The largest group is 75 to 84, with 1,072 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chalasani's median patient age at 76, with 38% women.

In 2024, Dr. Chalasani wrote 15,569 Medicare Part D claims for 2,827 patients. 85% of them were for generic drugs. CMS names the drug for 15,278 of them, across 80 drugs with 11 or more claims each, at $2,507,583 in total drug cost. In 2023, CMS named 11,101 claims across 71 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Chalasani for performance year 2024, reported as part of a group. Dr. Chalasani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 94 procedures of coronary angioplasty and stenting by Dr. Chalasani, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Chalasani, published from 2013 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Bacteremia, Endocarditis, Bacterial and Drug Hypersensitivity. Dr. Chalasani has published most often in Cureus. Dr. Chalasani's most frequent co-authors are Vishal Dahya, MD, Moti N. Ramgopal, MD and Jessica Maria Gonzalez, MD.

Dmand AI links Dr. Chalasani to 1 clinical trial. Conditions studied include Heart Failure, Diastolic and Heart Failure, Systolic.

CMS Open Payments shows 187 general payments to Dr. Chalasani from 20 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 56% of the total. Abbott Laboratories paid the most, $3,917. It also lists 1 research payment totaling $7,000 in 2018.

Dmand AI lists 2 awards for Dr. Chalasani, most recently Regional Top Doctor in 2014.

Dr. Chalasani graduated from Andhra Medical College NTR in 1987. Dr. Chalasani is a member of ACC.

Dr. Chalasani is in network with 16 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.